The efficacy of GLP-1 RAs for weight loss and remission of type 2 diabetes in the general population of obese adults is well documented and recommended by the UK’s National Institute for Health Care and Excellence (NICE) when used as a part of a specialised weight management service [29, 30]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.